About Cloverleaf Bio
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
New Haven, United States
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
cloverleafbio.com
Domain Registered Date
Jan 10, 2023
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $33,000,000 · Seed
hartfordbusiness.com
- Milestone
X account created (@cloverleafbio)
25 followers
- Milestone
Website domain registered
cloverleafbio.com
Investors & Backers
4BIO Capital
AbbVie
Boehringer Ingelheim Venture Fund
BrightEdge - American Cancer Society
Draper Associates
Eli Lilly
Mission BioCapital
Funding History
Seed
· Sep 8, 2026
$33,000,000 hartfordbusiness.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026